Table 4.
Distinctive features of primary large B-cell lymphomas of immune privileged sites.
| Subtypes | Primary large B-cell lymphoma of the CNS |
| Primary large B-cell lymphoma of the vitreoretina | |
| Primary large B-cell lymphoma of the testis | |
| Clinical | Usually in adults over age of 60 years |
| Lymphoma tends to “home” to other immune privileged sites: vitreoretina tumour may occur concurrently with or follow CNS tumour; testicular tumour tends to relapse in CNS or contralateral testis | |
| Aggressive tumours with generally poor prognosis | |
| Morphology | Large B-cell lymphoma |
| Immunophenotype | Activated B-cell immunophenotype: Usually CD10-, MUM1+, BCL6+ |
| EBV negative | |
| Mutational profile | Concomitant MYD88 and CD79B mutations |
| Immune evasion: genetic inactivation of MHC class I and II and B2M (β 2-microglobulin) with subsequent loss of protein expression | |
| Showing DLBCL genomic signature C5/MCD/MYD88 |